chr21-41741197-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020639.3(RIPK4):​c.1996A>G​(p.Met666Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.969 in 1,610,228 control chromosomes in the GnomAD database, including 755,817 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.98 ( 72936 hom., cov: 36)
Exomes 𝑓: 0.97 ( 682881 hom. )

Consequence

RIPK4
NM_020639.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.675

Publications

28 publications found
Variant links:
Genes affected
RIPK4 (HGNC:496): (receptor interacting serine/threonine kinase 4) The protein encoded by this gene is a serine/threonine protein kinase that interacts with protein kinase C-delta. The encoded protein can also activate NFkappaB and is required for keratinocyte differentiation. This kinase undergoes autophosphorylation. [provided by RefSeq, Jul 2008]
RIPK4 Gene-Disease associations (from GenCC):
  • Bartsocas-Papas syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • ectodermal dysplasia syndrome
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.0242087E-7).
BP6
Variant 21-41741197-T-C is Benign according to our data. Variant chr21-41741197-T-C is described in ClinVar as Benign. ClinVar VariationId is 261350.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.987 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RIPK4NM_020639.3 linkc.1996A>G p.Met666Val missense_variant Exon 8 of 8 ENST00000332512.8 NP_065690.2 Q9H4D1Q96T11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RIPK4ENST00000332512.8 linkc.1996A>G p.Met666Val missense_variant Exon 8 of 8 1 NM_020639.3 ENSP00000332454.3 P57078-2
RIPK4ENST00000352483.3 linkc.2140A>G p.Met714Val missense_variant Exon 9 of 9 5 ENSP00000330161.2 P57078-1
ENSG00000236883ENST00000423276.1 linkn.350T>C non_coding_transcript_exon_variant Exon 2 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.978
AC:
148901
AN:
152204
Hom.:
72879
Cov.:
36
show subpopulations
Gnomad AFR
AF:
0.995
Gnomad AMI
AF:
0.997
Gnomad AMR
AF:
0.991
Gnomad ASJ
AF:
0.982
Gnomad EAS
AF:
0.919
Gnomad SAS
AF:
0.887
Gnomad FIN
AF:
0.993
Gnomad MID
AF:
0.987
Gnomad NFE
AF:
0.974
Gnomad OTH
AF:
0.980
GnomAD2 exomes
AF:
0.967
AC:
237922
AN:
246154
AF XY:
0.963
show subpopulations
Gnomad AFR exome
AF:
0.996
Gnomad AMR exome
AF:
0.994
Gnomad ASJ exome
AF:
0.983
Gnomad EAS exome
AF:
0.918
Gnomad FIN exome
AF:
0.991
Gnomad NFE exome
AF:
0.974
Gnomad OTH exome
AF:
0.973
GnomAD4 exome
AF:
0.968
AC:
1410648
AN:
1457906
Hom.:
682881
Cov.:
89
AF XY:
0.966
AC XY:
699989
AN XY:
724970
show subpopulations
African (AFR)
AF:
0.997
AC:
33323
AN:
33424
American (AMR)
AF:
0.994
AC:
44269
AN:
44556
Ashkenazi Jewish (ASJ)
AF:
0.984
AC:
25575
AN:
25992
East Asian (EAS)
AF:
0.909
AC:
36039
AN:
39642
South Asian (SAS)
AF:
0.897
AC:
77128
AN:
85954
European-Finnish (FIN)
AF:
0.990
AC:
51253
AN:
51766
Middle Eastern (MID)
AF:
0.974
AC:
5616
AN:
5764
European-Non Finnish (NFE)
AF:
0.972
AC:
1079329
AN:
1110568
Other (OTH)
AF:
0.965
AC:
58116
AN:
60240
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
3230
6460
9689
12919
16149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21642
43284
64926
86568
108210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.978
AC:
149018
AN:
152322
Hom.:
72936
Cov.:
36
AF XY:
0.978
AC XY:
72805
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.995
AC:
41357
AN:
41584
American (AMR)
AF:
0.991
AC:
15177
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.982
AC:
3408
AN:
3470
East Asian (EAS)
AF:
0.919
AC:
4752
AN:
5170
South Asian (SAS)
AF:
0.886
AC:
4274
AN:
4822
European-Finnish (FIN)
AF:
0.993
AC:
10551
AN:
10626
Middle Eastern (MID)
AF:
0.986
AC:
290
AN:
294
European-Non Finnish (NFE)
AF:
0.974
AC:
66230
AN:
68020
Other (OTH)
AF:
0.979
AC:
2070
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
175
350
525
700
875
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.973
Hom.:
200594
Bravo
AF:
0.981
TwinsUK
AF:
0.973
AC:
3609
ALSPAC
AF:
0.976
AC:
3760
ESP6500AA
AF:
0.994
AC:
4380
ESP6500EA
AF:
0.973
AC:
8366
ExAC
AF:
0.965
AC:
116973
Asia WGS
AF:
0.918
AC:
3193
AN:
3478
EpiCase
AF:
0.972
EpiControl
AF:
0.973

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Bartsocas-Papas syndrome 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.045
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
5.3
DANN
Benign
0.54
DEOGEN2
Benign
0.036
T;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.014
N
LIST_S2
Benign
0.075
T;T
MetaRNN
Benign
6.0e-7
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.65
N;.
PhyloP100
0.68
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.050
N;N
REVEL
Benign
0.036
Sift
Benign
0.71
T;T
Sift4G
Benign
0.76
T;T
Polyphen
0.0
.;B
Vest4
0.0060
MPC
0.43
ClinPred
0.000017
T
GERP RS
-0.094
Varity_R
0.044
gMVP
0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3746891; hg19: chr21-43161357; COSMIC: COSV60189370; API